1. Home
  2. IPWR vs GANX Comparison

IPWR vs GANX Comparison

Compare IPWR & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ideal Power Inc.

IPWR

Ideal Power Inc.

BUY

Current Price

$2.76

Market Cap

65.4M

Sector

Industrials

ML Signal

BUY

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

BUY

Current Price

$1.28

Market Cap

76.8M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
IPWR
GANX
Founded
2007
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.4M
76.8M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
IPWR
GANX
Price
$2.76
$1.28
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $7.20
AVG Volume (30 Days)
113.8K
★ 619.8K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.46
EPS
N/A
★ N/A
Revenue
N/A
★ $55,180.00
Revenue This Year
$2,550.55
N/A
Revenue Next Year
$600.00
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.62
$1.15
52 Week High
$9.30
$4.34

Technical Indicators

Market Signals
Indicator
IPWR
GANX
Relative Strength Index (RSI) 24.56 30.94
Support Level $2.63 N/A
Resistance Level $3.33 $2.01
Average True Range (ATR) 0.24 0.11
MACD -0.05 -0.02
Stochastic Oscillator 6.60 21.67

Price Performance

Historical Comparison
IPWR
GANX

About IPWR Ideal Power Inc.

Ideal Power Inc is engaged in the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: